I-Diabetic Foot Ulcer Technology Itholakala Ngokokuqala ngqa e-India

I-India njengamanje ineziguli ezilinganiselwa ezigidini ezingama-77 zesifo sikashukela, okuyisibalo esiphezulu sesibili emhlabeni. Izilonda zonyawo lwesifo sikashukela zingenye yezinkinga ezibaluleke kakhulu nezilimazayo zesifo sikashukela futhi sichazwa njengonyawo oluthintekayo ngenxa yezilonda ezihambisana nesifo se-neuropathy kanye / noma i-peripheral arterial disease ye-arterial ephansi esigulini esinesifo sikashukela. Cishe, i-12-15% enesifo sikashukela ihlushwa i-DFU okungenani kanye empilweni. Ama-5–24% awo ekugcineni azoholela ekunqunyweni kwezitho phakathi nezinyanga eziyisi-6–18 ngemuva kokuhlolwa kokuqala. Ingozi yokuba nezilonda ezinyaweni kanye nokunqunywa kwesitho iyanda ngokuya ngeminyaka kanye nesikhathi sesifo sikashukela. U-Alkem usebenzisane ne-Rokit Healthcare Inc. ukwenza uhwebo ngobuchwepheshe e-India ukusiza ukunciphisa ukunqunywa kwezitho phakathi kweziguli ze-DFU uma kucatshangelwa umthelela omubi wokunqunywa kwezitho zomzimba eqophelweni lempilo yesiguli kanye nomthwalo wezomnotho ohambisana nawo ohlelweni lokunakekelwa kwezempilo.

UMnu. Sandeep Singh, uMqondisi Ophethe, i-Alkem Laboratories Ltd., uthe, “E-India, isifo sikashukela singenye yezinselelo ezinkulu zokunakekelwa kwempilo. Inselele ngokwayo inkulu kangangokuthi izilonda ezinyaweni zesifo sikashukela ngokuvamile azinakwa. Cishe i-lac eyodwa yabantu kufanele banqunywe izitho unyaka nonyaka futhi babeke engcupheni izinga lempilo yabo. Ukuze kuxazululwe le nkinga, i-Alkem isebenzisane ne-Rokit Healthcare Inc., inkampani yomhlaba wonke ekhiqiza izixazululo ezivuselelayo, ukuze kukhiqizwe izixazululo ezintsha zokulawula izilonda ezinyaweni ezinesifo sikashukela.”

Ukwengeza ngokuqhubekayo, uMnu. Sandeep wagomela, “I-Alkem, phakathi neminyaka edlule, ibilokhu ihamba phambili ekuletheni ukunakekelwa kweziguli okuseqophelweni eliphezulu, ngezinhlelo zayo ezintsha kanye nezinhlelo ezigxile esigulini.”